Halozyme Therapeutic (HALO) Stock Price, Quote & News

Company Profile

Halozyme Therapeutics, Inc., a biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 794 8889

Fax: 858 704 8311

Website: halozyme.com

Address:

12390 El Camino Real, San Diego, United States

topstockalerts Jul. 2 at 11:57 PM

Halozyme Therapeutics announced the departure of Chief Operating Officer Cortney Caudill, according to a Form 8-K filed with the U.S. Securities and Exchange Commission. The company said Caudill stepped down from her roles as Senior Vice President and Chief Operating Officer, effective June 30, 2026. Halozyme thanked her for her contributions during her tenure but did not disclose the reason for her departure, stating only that the filing reflected the executive leadership change. The company also did not name an interim or permanent successor or provide a timeline for filling the position. No additional changes to Halozyme's executive leadership or business strategy were announced alongside the filing. $HALO

0 · Reply

Jblack500 Jul. 2 at 11:03 PM

$HALO snuck that coo release in right before long holiday weekend. Worth adding to on a cool down before heading higher. I lightened up yesterday and was looking to add back 6 to 8% below my sell point. Thought ibb needed a short breather before heading higher but it continued to press up today

0 · Reply

Doozio Jul. 2 at 5:51 PM

Da $HALO shall protect Yo ENTA 🐒🍌🧠⏰♾️ AAOI. No moar AEHR balls.

0 · Reply

JFDI Jun. 30 at 1:27 PM

$HALO alerts at 71.5, 74.5 and 78.5. Would like to see price tighten up before highs.

0 · Reply

Sean29md Jun. 30 at 1:50 AM

$HALO https://www.cnbc.com/video/2026/06/29/final-trade-halo-baba-googl-spcx.html

0 · Reply

Sean29md Jun. 30 at 1:38 AM

$HALO On June 26, 2026, Jim Cramer and Jeff Marks of the https://www.cnbc.com/investingclub/morning-meeting/ specifically highlighted Halozyme Therapeutics, pointing to its extended product revenue runway.

0 · Reply

Doozio Jun. 29 at 10:10 PM

Or they go Thursday 🐑 in da $FATE of da YO then out of the tightness da $HALO protects YO ENTA 🐒🍌🧠⏰♾️

0 · Reply

JR603 Jun. 29 at 7:10 PM

$HALO FROM AI - PTAB Rulings: A Major Victory for Halozyme (June 29) The U.S. Patent Trial and Appeal Board (PTAB) issued a significant ruling.The Decision: The Board rejected Merck's arguments and upheld Halozyme’s challenged claims, ruling that Merck failed to prove they were "obvious".The Takeaway: The PTAB concluded that modifying the specific molecular structures in question would have required "undue experimentation" by prior art standards. This is a massive defensive win for Halozyme, preserving its core patent fortress as the broader District Court case moves forward in New Jersey.

1 · Reply

Jblack500 Jun. 29 at 6:19 PM

$GILD $HALO $ANIP $MRK gild added 125.8...the current basket, also holding ELAN ARWR

0 · Reply

kej32 Jun. 29 at 4:56 PM

$HALO ok looks like you are now ready! Just had to be patient!!!

0 · Reply

Market Cap	9.42B
Revenue (ttm)	1.40B
Net Income (ttm)	316.89M
EPS (ttm)	N/A
PE Ratio	18.21
Forward PE	10.21
Profit Margin	22.69%
Debt to Equity Ratio	9.76

Volume	1,566,200
Avg Vol	1,812,328
Day's Range	N/A - N/A
Shares Out	118.61M
Stochastic %K	99%
Beta	0.84
Analysts	Sell
Price Target	$83.82